Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 3
2017 5
2018 11
2019 7
2020 8
2021 9
2022 2
2023 7
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Results by year

Filters applied: . Clear all
Page 1
Risk of hypoglycemia in type 1 diabetes management: An in-silico sensitivity analysis to assess and rank the quantitative impact of different behavioral factors.
Roversi C, Camerlingo N, Vettoretti M, Facchinetti A, Choudhary P, Sparacino G, Del Favero S; Hypo-RESOLVE Consortium. Roversi C, et al. Among authors: vettoretti m. Comput Methods Programs Biomed. 2024 Feb;244:107943. doi: 10.1016/j.cmpb.2023.107943. Epub 2023 Nov 29. Comput Methods Programs Biomed. 2024. PMID: 38042693 Free article.
Artificial intelligence and statistical methods for stratification and prediction of progression in amyotrophic lateral sclerosis: A systematic review.
Tavazzi E, Longato E, Vettoretti M, Aidos H, Trescato I, Roversi C, Martins AS, Castanho EN, Branco R, Soares DF, Guazzo A, Birolo G, Pala D, Bosoni P, Chiò A, Manera U, de Carvalho M, Miranda B, Gromicho M, Alves I, Bellazzi R, Dagliati A, Fariselli P, Madeira SC, Di Camillo B. Tavazzi E, et al. Among authors: vettoretti m. Artif Intell Med. 2023 Aug;142:102588. doi: 10.1016/j.artmed.2023.102588. Epub 2023 May 20. Artif Intell Med. 2023. PMID: 37316101 Free article. Review.
Data Gap Modeling in Continuous Glucose Monitoring Sensor Data.
Drecogna M, Vettoretti M, Favero SD, Facchinetti A, Sparacino G. Drecogna M, et al. Among authors: vettoretti m. Annu Int Conf IEEE Eng Med Biol Soc. 2021 Nov;2021:4379-4382. doi: 10.1109/EMBC46164.2021.9629588. Annu Int Conf IEEE Eng Med Biol Soc. 2021. PMID: 34892190
Choosing the duration of continuous glucose monitoring for reliable assessment of time in range: A new analytical approach to overcome the limitations of correlation-based methods.
Camerlingo N, Vettoretti M, Sparacino G, Facchinetti A, Mader JK, Choudhary P, Del Favero S; Hypo-RESOLVE Consortium. Camerlingo N, et al. Among authors: vettoretti m. Diabet Med. 2022 May;39(5):e14758. doi: 10.1111/dme.14758. Epub 2021 Dec 16. Diabet Med. 2022. PMID: 34862829
Design of clinical trials to assess diabetes treatment: Minimum duration of continuous glucose monitoring data to estimate time-in-ranges with the desired precision.
Camerlingo N, Vettoretti M, Sparacino G, Facchinetti A, Mader JK, Choudhary P, Del Favero S; on behalf of the Hypo-RESOLVE Consortium. Camerlingo N, et al. Among authors: vettoretti m. Diabetes Obes Metab. 2021 Nov;23(11):2446-2454. doi: 10.1111/dom.14483. Epub 2021 Jul 21. Diabetes Obes Metab. 2021. PMID: 34212483 Free PMC article.
43 results